Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
02/24/2010 | EP2155753A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors |
02/24/2010 | EP2155747A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors |
02/24/2010 | EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
02/24/2010 | EP2155672A1 Prolinamide derivatives as nk3 antagonists |
02/24/2010 | EP2155202A2 3,6-disubstituted-imidazo[1,2-b]pyridazines and 3,5-disubstituted pyrazolo[1,5-a]pyrimidines as phosphatidylinositol-3-kinase inhibitors |
02/24/2010 | EP2059520B1 1,4,5,6,7,8-hexahydro-i,2,5-triaza-azulene derivatives as orexin receptor antagonists |
02/24/2010 | EP1713808B1 Two-phase method for the synthesis of selected pyrazolopyrimidines |
02/24/2010 | EP1706411B1 Method for preparing phthalocyanines |
02/24/2010 | EP1636225B1 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
02/24/2010 | EP1461316B1 Synthesis of 2-cyanoziridine-1-carboxamide |
02/24/2010 | CN101657455A Compounds for the treatment of hepatitis C |
02/24/2010 | CN101654455A Pyrrole [1, 2-a] imidazolium compound and preparation method and anti-tumor application thereof |
02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
02/23/2010 | US7667041 Cinnamide compound |
02/23/2010 | US7667037 Processes for preparation of ziprasidone |
02/23/2010 | US7667036 Pyrazolo[1,5-a]pyrimidine derivatives |
02/23/2010 | US7666897 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
02/18/2010 | WO2010019899A1 cMET INHIBITORS |
02/18/2010 | WO2010018868A1 Pest control agent containing triazolopyrimidine derivative or salt thereof |
02/18/2010 | WO2010018853A1 Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same |
02/18/2010 | WO2010018832A1 Catalyst for degrading lignin, catalyst for degrading aromatic hydrocarbon, and porphyrin |
02/18/2010 | WO2010018481A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
02/18/2010 | WO2010018327A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
02/18/2010 | WO2010017870A1 Bicyclic triazole derivatives for treating tumors |
02/18/2010 | WO2009158374A3 Inhibitors of akt activity |
02/18/2010 | US20100041881 Optically active ammonium salt compound, production intermediate thereof, and production method thereof |
02/18/2010 | US20100041681 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
02/18/2010 | US20100041676 Kinase inhibitors |
02/18/2010 | US20100041662 Heterocyclic compounds as antiinflammatory agents |
02/18/2010 | US20100041639 Cyclic malonamides as inhibitors of a beta protein production |
02/18/2010 | US20100041545 Catalysts and methods for catalytic oxidation |
02/18/2010 | CA2734077A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
02/18/2010 | CA2733941A1 Bicyclic triazole derivatives for the treatment of tumours |
02/18/2010 | CA2733528A1 Catalyst for the decomposition of lignin, method for the preparation of alcohols and organic acids, method for the preparation of lignin-decomposition products, catalyst for the decomposition of aromatic hydrocarbons, method for releasing hydrogen ions, as well as porphyrin |
02/18/2010 | CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists |
02/18/2010 | CA2732922A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
02/18/2010 | CA2731108A1 Cmet inhibitors |
02/17/2010 | EP2154140A1 Metallocenyl phthalocyanine compounds and use thereof in optical recording media |
02/17/2010 | EP2154139A1 Bicyclic heterocyclic compound |
02/17/2010 | EP2154135A1 Therapeutic agent for cerebral infarction |
02/17/2010 | EP2152714A1 Spiroindolinone derivatives |
02/17/2010 | EP2152713A1 Pyrazolopyrrolidines as inhibitors of gamma secretase |
02/17/2010 | EP2152712A1 Amino-heterocyclic compounds |
02/17/2010 | EP2152707A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
02/17/2010 | EP2152706A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use |
02/17/2010 | EP2152695A2 Gamma secretase modulators |
02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
02/17/2010 | EP2152271A1 Piperidine/piperazine derivatives |
02/17/2010 | EP2038285B1 Adenosine a2a receptor antagonists |
02/17/2010 | EP1828200B1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease. |
02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
02/17/2010 | CN101652368A processes for making zilpaterol and salts thereof |
02/17/2010 | CN101652367A Pyrimido [4, 5-D] azepine derivatives as 5-HT2C agonists |
02/17/2010 | CN101652366A New classical antifolates |
02/17/2010 | CN101648956A Method for extracting chlorophyll from silkworm excrement by using supercritical fluid |
02/17/2010 | CN101648955A Method for extracting chlorophyll from spirulina by using supercritical fluid |
02/17/2010 | CN101648954A Organic metallic complexes containing phthalocyanine compound and use thereof |
02/17/2010 | CN101648953A Imidazo (1,2-b) pyrrolo (1,2-f) pyridazine derivative as well as preparation method and application thereof |
02/17/2010 | CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
02/17/2010 | CN101647802A 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity and composition thereof |
02/16/2010 | US7663301 for use as robust red organic phosphors |
02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
02/16/2010 | US7662960 Structures have utility over a wide range of fields, including use as diagnostic and therapeutic agents; kinase inhibitors |
02/16/2010 | US7662846 Selective spirocyclic glucocorticoid receptor modulators |
02/16/2010 | US7662826 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same |
02/16/2010 | US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
02/16/2010 | US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances |
02/16/2010 | US7662808 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
02/16/2010 | US7662807 Sulphonated meso-tetraphenyl chlorins |
02/16/2010 | US7662362 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
02/16/2010 | CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
02/16/2010 | CA2410399C 5-aminoalkylpyrazolo[4,3-d]pyrimidines |
02/16/2010 | CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound |
02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
02/16/2010 | CA2309154C Substituted porphyrins |
02/16/2010 | CA2225822C Nitroimidazole antibacterial compounds and methods of use thereof |
02/11/2010 | WO2010017105A1 Urotensin ii receptor antagonists |
02/11/2010 | WO2010017093A2 Dopamine receptor ligands with enhanced duration of action |
02/11/2010 | WO2010017055A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
02/11/2010 | WO2010016005A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
02/11/2010 | WO2010015972A1 Diazepine and diazocane compounds as mc4 agonists |
02/11/2010 | WO2010015803A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
02/11/2010 | WO2010015545A1 Process for the preparation of a macrocycle |
02/11/2010 | WO2010015520A1 Substituted naphthyridines and use thereof as medicines |
02/11/2010 | US20100036123 Process for the preparation of 2,4-dichloro-7h-pyrrolo[2,3h]quinazoline |
02/11/2010 | US20100036121 Process for preparing temozolomide |
02/11/2010 | US20100036119 Fluorinating reagents and their preparation |
02/11/2010 | US20100036108 Universal Base |
02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
02/11/2010 | US20100035900 6-Arylmethyl-substituted pyrazolopyrimidines |
02/11/2010 | US20100035898 Organic compounds |
02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
02/11/2010 | CA2732797A1 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
02/11/2010 | CA2732762A1 Urotensin ii receptor antagonists |
02/11/2010 | CA2732165A1 Therapeutic agents 414 |
02/11/2010 | CA2732091A1 Process for the preparation of a macrocycle |